The increased BAFF levels in active patients may reflect increased BAFF production by dendritic cells exposed to nucleic acid-containing immune complexes, or could be related to disease-associated or therapy-associated B cell lymphopenia in both patients with active and patients with quiescent disease. This evidence concerns the gene TNFSF13B and Decreased total B cell count.